Quality assurance in human papillomavirus testing for primary cervical screening
The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based scree...
Gespeichert in:
| Veröffentlicht in: | International journal of gynecological cancer 2023-05, Vol.33 (5), p.802-811 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 811 |
|---|---|
| container_issue | 5 |
| container_start_page | 802 |
| container_title | International journal of gynecological cancer |
| container_volume | 33 |
| creator | Cuschieri, Kate Fellner, María Dolores Arroyo Mühr, Laila Sara Padalko, Elizaveta Correa, Rita Mariel Dillner, Joakim Gultekin, Murat Picconi, Maria Alejandra |
| description | The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential. |
| doi_str_mv | 10.1136/ijgc-2022-004197 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_D8T</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_447189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1048891X24024125</els_id><sourcerecordid>2786810214</sourcerecordid><originalsourceid>FETCH-LOGICAL-b579t-721fc0d09ddcaf6f89bae6fad600a55588733028be68b6e4d77bf8c7c57b2ef33</originalsourceid><addsrcrecordid>eNp9Uk2LFDEQDaK46-jdkwS8eLC1ku58eRFZ_IIFFRS8hXS6ejZjf8wm3SP7703T4-oK7ilF6r2Xl6pHyGMGLxgr5cuw2_qCA-cFQMWMukNOmeCiYFWp7-YaKl1ow76fkAcp7QDAcDD3yUkpDauYYqfk85fZdWG6oi6lObrBIw0DvZh7N9C924euG3t3CHFOdMI0hWFL2zHSfQy9i1fUYzwE7zqafEQccvshude6LuGj47kh3969_Xr2oTj_9P7j2ZvzohbKTIXirPXQgGka71rZalM7lK1rJIATQmityhK4rlHqWmLVKFW32isvVM2xLcsNKVbd9BP3c22Pjuzogj1e_cgV2qpSTJuMf73ic6fHxuMwRdfdoN3sDOHCbseDZcCULM3y4rOjQhwv5zwM24fksevcgOOcLFdaagY8D39Dnv4D3Y1zHPI8LNegtJLGiFtRWYtrwcRiHFaUj2NKEdtrzwzskgK7pMAuKbBrCjLlyd9_vSb8XnsGvFoBmDd0CBht8gHz8psQ0U-2GcNt6s9Xct3v_jj-L_wXwETRVg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786285159</pqid></control><display><type>article</type><title>Quality assurance in human papillomavirus testing for primary cervical screening</title><source>SWEPUB Freely available online</source><creator>Cuschieri, Kate ; Fellner, María Dolores ; Arroyo Mühr, Laila Sara ; Padalko, Elizaveta ; Correa, Rita Mariel ; Dillner, Joakim ; Gultekin, Murat ; Picconi, Maria Alejandra</creator><creatorcontrib>Cuschieri, Kate ; Fellner, María Dolores ; Arroyo Mühr, Laila Sara ; Padalko, Elizaveta ; Correa, Rita Mariel ; Dillner, Joakim ; Gultekin, Murat ; Picconi, Maria Alejandra</creatorcontrib><description>The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential.</description><identifier>ISSN: 1048-891X</identifier><identifier>EISSN: 1525-1438</identifier><identifier>DOI: 10.1136/ijgc-2022-004197</identifier><identifier>PMID: 36914171</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Cellular biology ; Cervical Cancer ; Cervix Uteri ; Early Detection of Cancer ; FDA approval ; Female ; Genetic testing ; Human papillomavirus ; Human Papillomavirus Viruses ; Humans ; Infections ; Laboratories ; Mass Screening ; Medical screening ; Papillomaviridae ; Papillomavirus Infections ; Public health ; Quality control ; Quality standards ; Reproducibility ; Review ; Uterine Cervical Neoplasms - diagnosis ; Vaccines ; Vaginal Smears ; Viral infections</subject><ispartof>International journal of gynecological cancer, 2023-05, Vol.33 (5), p.802-811</ispartof><rights>IGCS and ESGO 2023. Re-use permitted under CC BY. Published by BMJ.</rights><rights>2023 IGCS and ESGO 2023. Re-use permitted under CC BY. Published by BMJ.</rights><rights>2023 IGCS and ESGO 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>IGCS and ESGO 2023. Re-use permitted under CC BY. Published by BMJ. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b579t-721fc0d09ddcaf6f89bae6fad600a55588733028be68b6e4d77bf8c7c57b2ef33</citedby><cites>FETCH-LOGICAL-b579t-721fc0d09ddcaf6f89bae6fad600a55588733028be68b6e4d77bf8c7c57b2ef33</cites><orcidid>0000-0003-2498-5206 ; 0000-0002-4221-4459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,550,776,881</link.rule.ids><linktorsrc>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:152216578$$EView_record_in_Swedish_Publication_Index_(SWEPUB)$$FView_record_in_$$GSwedish_Publication_Index_(SWEPUB)$$Hfree_for_read</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36914171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:152216578$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Cuschieri, Kate</creatorcontrib><creatorcontrib>Fellner, María Dolores</creatorcontrib><creatorcontrib>Arroyo Mühr, Laila Sara</creatorcontrib><creatorcontrib>Padalko, Elizaveta</creatorcontrib><creatorcontrib>Correa, Rita Mariel</creatorcontrib><creatorcontrib>Dillner, Joakim</creatorcontrib><creatorcontrib>Gultekin, Murat</creatorcontrib><creatorcontrib>Picconi, Maria Alejandra</creatorcontrib><title>Quality assurance in human papillomavirus testing for primary cervical screening</title><title>International journal of gynecological cancer</title><addtitle>Int J Gynecol Cancer</addtitle><addtitle>Int J Gynecol Cancer</addtitle><description>The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential.</description><subject>Cellular biology</subject><subject>Cervical Cancer</subject><subject>Cervix Uteri</subject><subject>Early Detection of Cancer</subject><subject>FDA approval</subject><subject>Female</subject><subject>Genetic testing</subject><subject>Human papillomavirus</subject><subject>Human Papillomavirus Viruses</subject><subject>Humans</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Mass Screening</subject><subject>Medical screening</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections</subject><subject>Public health</subject><subject>Quality control</subject><subject>Quality standards</subject><subject>Reproducibility</subject><subject>Review</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Vaccines</subject><subject>Vaginal Smears</subject><subject>Viral infections</subject><issn>1048-891X</issn><issn>1525-1438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>ACMMV</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><recordid>eNp9Uk2LFDEQDaK46-jdkwS8eLC1ku58eRFZ_IIFFRS8hXS6ejZjf8wm3SP7703T4-oK7ilF6r2Xl6pHyGMGLxgr5cuw2_qCA-cFQMWMukNOmeCiYFWp7-YaKl1ow76fkAcp7QDAcDD3yUkpDauYYqfk85fZdWG6oi6lObrBIw0DvZh7N9C924euG3t3CHFOdMI0hWFL2zHSfQy9i1fUYzwE7zqafEQccvshude6LuGj47kh3969_Xr2oTj_9P7j2ZvzohbKTIXirPXQgGka71rZalM7lK1rJIATQmityhK4rlHqWmLVKFW32isvVM2xLcsNKVbd9BP3c22Pjuzogj1e_cgV2qpSTJuMf73ic6fHxuMwRdfdoN3sDOHCbseDZcCULM3y4rOjQhwv5zwM24fksevcgOOcLFdaagY8D39Dnv4D3Y1zHPI8LNegtJLGiFtRWYtrwcRiHFaUj2NKEdtrzwzskgK7pMAuKbBrCjLlyd9_vSb8XnsGvFoBmDd0CBht8gHz8psQ0U-2GcNt6s9Xct3v_jj-L_wXwETRVg</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>Cuschieri, Kate</creator><creator>Fellner, María Dolores</creator><creator>Arroyo Mühr, Laila Sara</creator><creator>Padalko, Elizaveta</creator><creator>Correa, Rita Mariel</creator><creator>Dillner, Joakim</creator><creator>Gultekin, Murat</creator><creator>Picconi, Maria Alejandra</creator><general>BMJ Publishing Group Ltd</general><general>Elsevier Inc</general><general>Elsevier Limited</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0003-2498-5206</orcidid><orcidid>https://orcid.org/0000-0002-4221-4459</orcidid></search><sort><creationdate>20230501</creationdate><title>Quality assurance in human papillomavirus testing for primary cervical screening</title><author>Cuschieri, Kate ; Fellner, María Dolores ; Arroyo Mühr, Laila Sara ; Padalko, Elizaveta ; Correa, Rita Mariel ; Dillner, Joakim ; Gultekin, Murat ; Picconi, Maria Alejandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b579t-721fc0d09ddcaf6f89bae6fad600a55588733028be68b6e4d77bf8c7c57b2ef33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cellular biology</topic><topic>Cervical Cancer</topic><topic>Cervix Uteri</topic><topic>Early Detection of Cancer</topic><topic>FDA approval</topic><topic>Female</topic><topic>Genetic testing</topic><topic>Human papillomavirus</topic><topic>Human Papillomavirus Viruses</topic><topic>Humans</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Mass Screening</topic><topic>Medical screening</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections</topic><topic>Public health</topic><topic>Quality control</topic><topic>Quality standards</topic><topic>Reproducibility</topic><topic>Review</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Vaccines</topic><topic>Vaginal Smears</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cuschieri, Kate</creatorcontrib><creatorcontrib>Fellner, María Dolores</creatorcontrib><creatorcontrib>Arroyo Mühr, Laila Sara</creatorcontrib><creatorcontrib>Padalko, Elizaveta</creatorcontrib><creatorcontrib>Correa, Rita Mariel</creatorcontrib><creatorcontrib>Dillner, Joakim</creatorcontrib><creatorcontrib>Gultekin, Murat</creatorcontrib><creatorcontrib>Picconi, Maria Alejandra</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>International journal of gynecological cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cuschieri, Kate</au><au>Fellner, María Dolores</au><au>Arroyo Mühr, Laila Sara</au><au>Padalko, Elizaveta</au><au>Correa, Rita Mariel</au><au>Dillner, Joakim</au><au>Gultekin, Murat</au><au>Picconi, Maria Alejandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quality assurance in human papillomavirus testing for primary cervical screening</atitle><jtitle>International journal of gynecological cancer</jtitle><stitle>Int J Gynecol Cancer</stitle><addtitle>Int J Gynecol Cancer</addtitle><date>2023-05-01</date><risdate>2023</risdate><volume>33</volume><issue>5</issue><spage>802</spage><epage>811</epage><pages>802-811</pages><issn>1048-891X</issn><eissn>1525-1438</eissn><abstract>The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based screening are needed that are ideally applicable for a variety of settings, including in low- and middle-income countries. We summarize the main points of quality assurance for HPV screening, with a focus on the selection, implementation, and use of an HPV screening test, quality assurance systems (including internal quality control and external quality assessment), and staff competence. While we recognize that it might not be possible to fulfill all points in all settings, an awareness of the issues is essential.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>36914171</pmid><doi>10.1136/ijgc-2022-004197</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-2498-5206</orcidid><orcidid>https://orcid.org/0000-0002-4221-4459</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1048-891X |
| ispartof | International journal of gynecological cancer, 2023-05, Vol.33 (5), p.802-811 |
| issn | 1048-891X 1525-1438 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_447189 |
| source | SWEPUB Freely available online |
| subjects | Cellular biology Cervical Cancer Cervix Uteri Early Detection of Cancer FDA approval Female Genetic testing Human papillomavirus Human Papillomavirus Viruses Humans Infections Laboratories Mass Screening Medical screening Papillomaviridae Papillomavirus Infections Public health Quality control Quality standards Reproducibility Review Uterine Cervical Neoplasms - diagnosis Vaccines Vaginal Smears Viral infections |
| title | Quality assurance in human papillomavirus testing for primary cervical screening |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A00%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_D8T&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quality%20assurance%20in%20human%20papillomavirus%20testing%20for%20primary%20cervical%20screening&rft.jtitle=International%20journal%20of%20gynecological%20cancer&rft.au=Cuschieri,%20Kate&rft.date=2023-05-01&rft.volume=33&rft.issue=5&rft.spage=802&rft.epage=811&rft.pages=802-811&rft.issn=1048-891X&rft.eissn=1525-1438&rft_id=info:doi/10.1136/ijgc-2022-004197&rft_dat=%3Cproquest_D8T%3E2786810214%3C/proquest_D8T%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2786285159&rft_id=info:pmid/36914171&rft_els_id=S1048891X24024125&rfr_iscdi=true |